Brief: Immunovia Q2 Loss Before Tax Widens To SEK 29.9 Million

Immunovia AB (publ)

23/08/2019 14:19

Aug 23 (Reuters) - Immunovia AB (publ)  IMMNOV.ST :
    * Q2 NET SALES SEK 154,000 VERSUS SEK 44,000 YEAR AGO
    * Q2 LOSS BEFORE TAX 29.9 MILLION VERSUS LOSS SEK 26,1
MILLION
YEAR AGO
    * IMMRAY PANCAN-D, CO'S BLOOD-BASED TEST FOR EARLY DETECTION
OF
PANCREATIC CANCER, IS NOW SET FOR Q3 2020 LAUNCH

Source text for Eikon:  ID:nWkr1YVP33 
Further company coverage:  IMMNOV.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 587720920;))